Under way, not recruiting
Shortened Course Adjuvant Radiotherapy Following TORS
NCT05714657 · Abramson Cancer Center at Penn Medicine · Updated 30 April 2026
- What is being tested
- Shortened Course Adjuvant Radiotherapy Following TORS
- For
- HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 104 people. The full rules are on the registry page.
- Where
- United States (3 sites)
- When
- Starts or started 30 Jan 2023, ends 30 Dec 2026. Registered 6 Feb 2023.
- Results
- None posted yet.
In the researchers' words
This is a single-arm, phase II study to establish the safety of reducing radiation dose in selected HPV-Associated OPSCC patients receiving adjuvant radiation after TORS and neck dissection. This protocol also allows for sparing of the primary resection bed, in appropriate patients, as previously published by our group and found to be safe and effective.
Sites
- Lancaster General HospitalLancaster, Pennsylvania, United States
- University of PennsylvaniaPhiladelphia, Pennsylvania, United States
- Pennsylvania HospitalPhiladelphia, Pennsylvania, United States